Stock Scorecard
Stock Summary for Danaher Corp (DHR) - $245.80 as of 4/26/2024 3:08:27 PM EST
Total Score
7 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DHR
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DHR
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DHR
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for DHR
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for DHR
Financial Details for DHR
Company Overview |
|
---|---|
Ticker | DHR |
Company Name | Danaher Corp |
Country | USA |
Description | Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions. |
Sector Name | LIFE SCIENCES |
Industry Name | INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL |
Most Recent Quarter | 3/31/2024 |
Next Earnings Date | 7/23/2024 |
Stock Price History |
|
Last Day Price | 245.80 |
Last Day Price Updated | 4/26/2024 3:08:27 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 2,862,521 |
52-Week High | 258.72 |
52-Week Low | 181.70 |
Last Price to 52 Week Low | 35.28% |
Valuation Measures |
|
Trailing PE | 45.86 |
Industry PE | 110.30 |
Sector PE | 56.64 |
5-Year Average PE | 47.59 |
Free Cash Flow Ratio | 25.90 |
Industry Free Cash Flow Ratio | 54.91 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 1.85 |
Total Cash Per Share | 9.49 |
Book Value Per Share Most Recent Quarter | 72.16 |
Price to Book Ratio | 3.32 |
Industry Price to Book Ratio | 3.04 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 7.44 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.11 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 740,687,000 |
Market Capitalization | 182,060,864,600 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/27/2024 |
Last Dividend Amount | 0.24 |
Current Dividend Amount | 0.27 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 1.05 |
Trailing Annual Dividend Yield | 0.43% |
Forward Annual Dividend Rate | 1.17 |
Forward Annual Dividend Yield | 0.48% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 0.39% |
5-Year Average Dividend Yield | 0.41% |
1-Year Dividend Growth Rate Percentage | 5.00% |
3-Year Dividend Growth Rate Percentage | 11.80% |
5-Year Dividend Growth Rate Percentage | 11.47% |
All-Time Dividend Growth Rate Percentage | 17.85% |
Dividend Payout Ratio | 19.23% |
Income Statement |
|
Quarterly Earnings Growth YOY | -25.10% |
Annual Earnings Growth | -33.92% |
Reported EPS 12 Trailing Months | 5.46 |
Reported EPS Past Year | 1.92 |
Reported EPS Prior Year | 8.52 |
Net Income Twelve Trailing Months | 4,402,000,000 |
Net Income Past Year | 4,764,000,000 |
Net Income Prior Year | 7,209,000,000 |
Quarterly Revenue Growth YOY | -2.60% |
5-Year Revenue Growth | 3.56% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 7,031,000,000 |
Total Cash Past Year | 5,864,000,000 |
Total Cash Prior Year | 5,995,000,000 |
Net Cash Position Most Recent Quarter | -11,132,000,000 |
Net Cash Position Past Year | -12,538,000,000 |
Long Term Debt Past Year | 18,402,000,000 |
Long Term Debt Prior Year | 19,677,000,000 |
Total Debt Most Recent Quarter | 18,163,000,000 |
Equity to Debt Ratio Past Year | 0.74 |
Equity to Debt Ratio Most Recent Quarter | 0.75 |
Total Stockholder Equity Past Year | 53,486,000,000 |
Total Stockholder Equity Prior Year | 50,082,000,000 |
Total Stockholder Equity Most Recent Quarter | 53,442,000,000 |
Options |
|
Put/Call Ratio | 0.98 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.72 |
MACD Signal | -1.73 |
20-Day Bollinger Lower Band | 221.36 |
20-Day Bollinger Middle Band | 241.31 |
20-Day Bollinger Upper Band | 261.27 |
Beta | 0.86 |
RSI | 54.64 |
50-Day SMA | 223.60 |
200-Day SMA | 226.14 |
System |
|
Modified | 4/26/2024 10:51:15 PM EST |